Life AI Net
Inicio
Archivo
Calculadoras
Directorio
Boletín
Hot
Iniciar sesión
Español
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Inicio
Archivo
Calculadoras
Directorio
Boletín
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Iniciar sesión
Inicio
Archivo
Calculadoras
Directorio
More
En vivo
Cell
A skin-hypothalamus axis couples heat stress and metabolic dysfunction
Cell
The evolution of high-order genome architecture revealed from 1,000 species
Cell
Somatic cancer variants enriched in Alzheimer’s disease microglia-like cells drive inflammatory and proliferative states
Cell
Pyruvate is a natural suppressor of interferon signaling by inducing STAT1 protein pyruvylation
Cell
Mechanism-guided identification of antidepressant G protein-coupled receptor drug targets
BD
Area Softball: PRB gets 2 wins - Brainerd Dispatch
FierceBiotech
WCG acquires The Contract Network in bid to streamline clinical trial execution
Recursion
Recursion Pharmaceuticals director Gibson sells $144,400 in stock By Investing.com - Investing.com Canada
Recursion
Recursion Pharmaceuticals (NASDAQ: RXRX) director sells 40K shares under plan - Stock Titan
Recursion
[SCHEDULE 13G/A] RECURSION PHARMACEUTICALS, INC. Amended Passive Investment Disclosure - Stock Titan
Cell
A skin-hypothalamus axis couples heat stress and metabolic dysfunction
Cell
The evolution of high-order genome architecture revealed from 1,000 species
Cell
Somatic cancer variants enriched in Alzheimer’s disease microglia-like cells drive inflammatory and proliferative states
Cell
Pyruvate is a natural suppressor of interferon signaling by inducing STAT1 protein pyruvylation
Cell
Mechanism-guided identification of antidepressant G protein-coupled receptor drug targets
BD
Area Softball: PRB gets 2 wins - Brainerd Dispatch
FierceBiotech
WCG acquires The Contract Network in bid to streamline clinical trial execution
Recursion
Recursion Pharmaceuticals director Gibson sells $144,400 in stock By Investing.com - Investing.com Canada
Recursion
Recursion Pharmaceuticals (NASDAQ: RXRX) director sells 40K shares under plan - Stock Titan
Recursion
[SCHEDULE 13G/A] RECURSION PHARMACEUTICALS, INC. Amended Passive Investment Disclosure - Stock Titan
Archivo
BioWorld
3 dic 2025
Financings for Dec. 3, 2025
Financings for Dec. 3, 2025
Original
Contenido no disponible. Consulta la fuente original.